Database

Startups

Main Industry
Biotechnology
Main Product/Service
TGIA offers high-throughput next-generation and third-generation sequencing services in Taiwan, utilising industry-grade systems such as Illumina NovaSeq X Plus, NovaSeq 6000 and PacBio Sequel IIe.
Their service portfolio spans whole genome sequencing a
Founded Year
2017
Unified Business No.
52608581
Status
Active
Number of Employees
0
Total Paid-in Capital
192,432,060 (NT$)
Location of Company
Taiwan , Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
Taiwan Genomic Industry Alliance Inc. (TGIA) is a Taiwan-based company located in Nankang Software Park and, since 2022, headquartered in Hsinchu Biomedical Science Park as its operational and R&D center. Established under the guidance of the “Asia Pacific Biomedical Silicon Valley Precision Medicine Program” operated by the National Health Research Institutes (NHRI) in 2017, TGIA collaborates with NHRI through technology transfer to become a leading player in disease, genetics and cancer-genetics sequencing, serving as an important medical hub in the Asia-Pacific region



More ↓

Similar Companies

CrackerBio, Inc.

1. NextAmp™ Analysis System
2. PanelChip®
3. DigiChip™ Digital PCR
4. ThyroSCAN
5. FusionQuest

PHALANX BIOTECH

Maternal and Child Health Testing: Provides prenatal and postnatal chromosomal microarray screening, such as CytoOneArray, which can screen for more than 400 genetic disorders in a single test, including chromosomal abnormalities and developmental delays.
Precision Oncology: Develops breakthrough ctDNA methylation technology for early liver cancer screening, while also providing pharmacogenomic testing services for cancers such as breast cancer, colorectal cancer, and lung cancer.
Gynecologic Cancer Screening: Offers services such as the AmpliGene Test, enabling simultaneous screening for endometrial cancer and cervical cancer.
Research and Contract Manufacturing: Possesses high-density gene chip R&D and manufacturing capabilities, and provides customized gene chip design and processing services on an ODM/OEM basis.